NCT03115463

Brief Summary

The purpose of this research project is to determine if use of optimized target oxygen strategy during delivery room resuscitation can reduce oxidative stress in premature newborns. Objective is to compare oxidative stress markers between preterm neonates resuscitated in the delivery room using three different target oxygen strategies. OX50 target oxygen strategy is currently in use and recommended by neonatal resuscitation program. In this strategy oxygen is adjusted to meet the goal transitional saturations which are approximated 50th centile saturations observed in healthy term newborns. In OX25 target oxygen strategy oxygen will be adjusted to meet the goal transitional saturations which are 25th percentile transitional saturations observed in healthy term newborns. In OX75 target oxygen strategy oxygen will be adjusted to meet the goal transitional saturations which are 75th percentile transitional saturations observed in healthy term newborns.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 14, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 14, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

September 20, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2019

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
Last Updated

January 4, 2023

Status Verified

December 1, 2022

Enrollment Period

2 years

First QC Date

March 14, 2017

Last Update Submit

December 30, 2022

Conditions

Keywords

Neonatal ResuscitationPrematurityOxygen

Outcome Measures

Primary Outcomes (1)

  • Change in Oxidative Balance Ratio from Baseline

    Difference in oxidative balance ratio between Cord blood and postnatal sample obtained within 2 hours of life will be assessed.

    within 2 hours after Birth

Secondary Outcomes (11)

  • Reduction in Isoprostane,Isofluran, 8-OHdG and protein carbonyls

    Within 2 hours after birth and at 24 hours

  • • Reduction in oxygen load in the delivery room

    During resuscitation in the delivery room for the first 15 minutes of life

  • Time spent in goal saturations

    During resuscitation in the delivery room

  • Incidence of bradycardia during resuscitation

    During resuscitation in the delivery room

  • intubation in the delivery room

    During resuscitation in the delivery room

  • +6 more secondary outcomes

Study Arms (3)

OX25

EXPERIMENTAL

Resuscitation will be initiated at 30% O2. Titration of oxygen during neonatal resuscitation: Intervention is target goal saturations which will be the 10th to 25th percentile saturations observed in healthy term newborns.

Other: Titration of oxygen during neonatal resuscitation

OX50

NO INTERVENTION

Resuscitation will be initiated with 30% O2 and target goal saturations will be the approximated median SpO2 observed in healthy term newborns as per current NRP guidelines

OX75

ACTIVE COMPARATOR

Resuscitation will be initiated at 30% O2. Titration of oxygen during neonatal resuscitation: Intervention is target goal saturations which will be the 75th percentile saturations observed in healthy term newborns.

Other: Titration of oxygen during neonatal resuscitation

Interventions

Resuscitation will be initiated at 30% O2 and target goal saturations will be the 10th to 25th percentile saturations in OX25 and 75th percentile in OX75 group. The control group will be resuscitated with the OX50 strategy in which resuscitation will be initiated with 30% O2 and target goal saturations will be the approximated median SpO2 observed in healthy term newborns as per current NRP guidelines. For the first 6 minutes after birth, target ranges of of all 3 arms are different. After 6 min, the target ranges are are identical.

OX25OX75

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Neonates of obstetric gestational age 23-30 weeks
  • Inborn at Parkland Hospital, Dallas, Tx
  • Resuscitation team present to initiate resuscitation

You may not qualify if:

  • Prenatally diagnosed cyanotic congenital heart disease
  • Prenatally diagnosed congenital diaphragmatic hernia
  • Prenatally diagnosed significant airway anomaly
  • Prenatally suspected hypoplasia of lungs
  • Preductal saturation cannot be measured
  • Non-viable newborns
  • Prenatally diagnosed condition due to which decision is made to limit resuscitation in the delivery room by parents and neonatologist.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Parkland Hospital

Dallas, Texas, 75039, United States

Location

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Vishal Kapadia, MD

    University of Texas Southwestern Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Clinical care team in the neonatal intensive care unit, investigators running the oxidative stress measurements and investigator assessing neurodevelopmental outcomes will be blinded to which arm the infant was randomized to in the delivery room.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Pediatrics

Study Record Dates

First Submitted

March 14, 2017

First Posted

April 14, 2017

Study Start

September 20, 2017

Primary Completion

September 30, 2019

Study Completion

September 30, 2022

Last Updated

January 4, 2023

Record last verified: 2022-12

Locations